CERIBELL INC (CBLL) Fundamental Analysis & Valuation

NASDAQ:CBLL • US15678C1027

Current stock price

21.1 USD
+0.16 (+0.76%)
Last:

This CBLL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CBLL Profitability Analysis

1.1 Basic Checks

  • CBLL had negative earnings in the past year.
  • In the past year CBLL has reported a negative cash flow from operations.
CBLL Yearly Net Income VS EBIT VS OCF VS FCFCBLL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -10M -20M -30M -40M -50M

1.2 Ratios

  • CBLL's Return On Assets of -27.28% is in line compared to the rest of the industry. CBLL outperforms 44.38% of its industry peers.
  • CBLL has a Return On Equity (-34.38%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -27.28%
ROE -34.38%
ROIC N/A
ROA(3y)-31.74%
ROA(5y)N/A
ROE(3y)-46.45%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBLL Yearly ROA, ROE, ROICCBLL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • CBLL has a better Gross Margin (87.89%) than 96.79% of its industry peers.
  • CBLL's Gross Margin has improved in the last couple of years.
  • CBLL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.96%
GM growth 5YN/A
CBLL Yearly Profit, Operating, Gross MarginsCBLL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. CBLL Health Analysis

2.1 Basic Checks

  • CBLL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CBLL has been increased compared to 1 year ago.
  • The debt/assets ratio for CBLL is higher compared to a year ago.
CBLL Yearly Shares OutstandingCBLL Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 10M 20M 30M
CBLL Yearly Total Debt VS Total AssetsCBLL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • An Altman-Z score of 10.61 indicates that CBLL is not in any danger for bankruptcy at the moment.
  • CBLL has a better Altman-Z score (10.61) than 88.77% of its industry peers.
  • CBLL has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
  • CBLL has a Debt to Equity ratio of 0.13. This is in the better half of the industry: CBLL outperforms 63.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 10.61
ROIC/WACCN/A
WACC8.87%
CBLL Yearly LT Debt VS Equity VS FCFCBLL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 9.73 indicates that CBLL has no problem at all paying its short term obligations.
  • The Current ratio of CBLL (9.73) is better than 91.98% of its industry peers.
  • A Quick Ratio of 9.35 indicates that CBLL has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 9.35, CBLL belongs to the top of the industry, outperforming 92.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 9.73
Quick Ratio 9.35
CBLL Yearly Current Assets VS Current LiabilitesCBLL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. CBLL Growth Analysis

3.1 Past

  • CBLL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.54%.
  • Looking at the last year, CBLL shows a very strong growth in Revenue. The Revenue has grown by 36.09%.
  • CBLL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 50.90% yearly.
EPS 1Y (TTM)-29.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10%
Revenue 1Y (TTM)36.09%
Revenue growth 3Y50.9%
Revenue growth 5YN/A
Sales Q2Q%33.72%

3.2 Future

  • CBLL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.02% yearly.
  • CBLL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 28.22% yearly.
EPS Next Y-1.04%
EPS Next 2Y14.08%
EPS Next 3Y12.02%
EPS Next 5YN/A
Revenue Next Year28.3%
Revenue Next 2Y28.37%
Revenue Next 3Y28.22%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CBLL Yearly Revenue VS EstimatesCBLL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
CBLL Yearly EPS VS EstimatesCBLL Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. CBLL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CBLL. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CBLL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CBLL Price Earnings VS Forward Price EarningsCBLL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBLL Per share dataCBLL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CBLL's earnings are expected to grow with 12.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.08%
EPS Next 3Y12.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CBLL Dividend Analysis

5.1 Amount

  • CBLL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CBLL Fundamentals: All Metrics, Ratios and Statistics

CERIBELL INC

NASDAQ:CBLL (4/22/2026, 3:01:59 PM)

21.1

+0.16 (+0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-24
Earnings (Next)05-06
Inst Owners74.74%
Inst Owner Change-0.02%
Ins Owners10.34%
Ins Owner Change7.58%
Market Cap794.20M
Revenue(TTM)89.06M
Net Income(TTM)-53.41M
Analysts88.57
Price Target28.41 (34.64%)
Short Float %6.53%
Short Ratio6.22
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.34%
Min EPS beat(2)12.27%
Max EPS beat(2)14.41%
EPS beat(4)4
Avg EPS beat(4)12.11%
Min EPS beat(4)5.13%
Max EPS beat(4)16.63%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.58%
Min Revenue beat(2)1.49%
Max Revenue beat(2)1.68%
Revenue beat(4)4
Avg Revenue beat(4)2.29%
Min Revenue beat(4)1.49%
Max Revenue beat(4)4.36%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.02%
PT rev (3m)-0.51%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.72%
EPS NY rev (1m)0.26%
EPS NY rev (3m)0.35%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.92
P/FCF N/A
P/OCF N/A
P/B 5.11
P/tB 5.11
EV/EBITDA N/A
EPS(TTM)-1.47
EYN/A
EPS(NY)-1.49
Fwd EYN/A
FCF(TTM)-1.12
FCFYN/A
OCF(TTM)-1.08
OCFYN/A
SpS2.37
BVpS4.13
TBVpS4.13
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -27.28%
ROE -34.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 87.89%
FCFM N/A
ROA(3y)-31.74%
ROA(5y)N/A
ROE(3y)-46.45%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.96%
GM growth 5YN/A
F-Score3
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 113.5%
Cap/Sales 1.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.73
Quick Ratio 9.35
Altman-Z 10.61
F-Score3
WACC8.87%
ROIC/WACCN/A
Cap/Depr(3y)153.9%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.68%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10%
EPS Next Y-1.04%
EPS Next 2Y14.08%
EPS Next 3Y12.02%
EPS Next 5YN/A
Revenue 1Y (TTM)36.09%
Revenue growth 3Y50.9%
Revenue growth 5YN/A
Sales Q2Q%33.72%
Revenue Next Year28.3%
Revenue Next 2Y28.37%
Revenue Next 3Y28.22%
Revenue Next 5YN/A
EBIT growth 1Y-47.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year10.43%
EBIT Next 3Y16.97%
EBIT Next 5YN/A
FCF growth 1Y-15.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.45%
OCF growth 3YN/A
OCF growth 5YN/A

CERIBELL INC / CBLL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CERIBELL INC?

ChartMill assigns a fundamental rating of 4 / 10 to CBLL.


What is the valuation status of CERIBELL INC (CBLL) stock?

ChartMill assigns a valuation rating of 0 / 10 to CERIBELL INC (CBLL). This can be considered as Overvalued.


How profitable is CERIBELL INC (CBLL) stock?

CERIBELL INC (CBLL) has a profitability rating of 2 / 10.


How financially healthy is CERIBELL INC?

The financial health rating of CERIBELL INC (CBLL) is 6 / 10.